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Preeclampsia (PE) is one of the main causes of maternal and fetal mortality and morbidity. PE is associated with an inﬂammatory
state and with oxidative stress, in maternal circulation. Our aim was to evaluate and compare the levels of oxidative stress and
inﬂammatory markers in maternal and umbilical cord blood (UCB), in normal and PE pregnancies. We measured acute-phase
proteins (CRP and α1-antitrypsin), proinﬂammatory cytokines (IL-6 and TNF-α), leukocyte activation (elastase, lactoferrin, sL-
selectin, sVCAM, sPECAM), total antioxidant status (TAS), thiobarbituric acid reactive substances (TBARS), and uric acid levels.
We studied 42 healthy pregnant women, 46 PE women, and their neonates. The concentrations of IL-6, TNF-α, α1-antitrypsin,
CRP, sVCAM, uric acid, and TBARS were signiﬁcantly higher, and sL-selectin was signiﬁcantly lower in PE pregnant women as
comparedwithnormotensivepregnantwomen.Innewbornsuricacid,α1-antitrypsin,andCRPvaluesweresigniﬁcantlyhigherin
PE;leukocytecount,sL-selectin,lactoferrin,andtheratioelastase/α1-antitrypsinweresigniﬁcantlylower.OurdatasuggestthatPE
pregnancy is associated with an enhanced maternal inﬂammatory condition, which is reﬂected in fetal circulation. This enhanced
inﬂammatory state seems to be related to endothelial dysfunction and increased cytokine synthesis, rather than with neutrophil
activation.
1.Introduction
Preeclampsia (PE) is a human speciﬁc pregnancy and multi-
system disorder, which may cause maternal and neonatal
morbidity and mortality. The speciﬁc cause for this syn-
drome remains unclear, despite the intense investigation. It
has been reported that an altered lipid proﬁle [1], leukocyte
activation [2], enhanced inﬂammatory response [3], and
oxidative stress [4], in maternal circulation, are frequently
associated with development of this disorder. In PE, the
hypoperfused placenta is a potential source of reactive
oxygenspecies(ROS)andcytokines[5,6],whichmayinduce
oxidative stress and endothelial cell dysfunction, as well as an
inﬂammatory response, in the mother.
An inﬂammatory response is usually accompanied by
increasing concentrations of proinﬂammatory cytokines,
acute-phase proteins and may involve leukocyte activation
[7]. Tumor necrosis factor-alpha (TNF-alpha) and IL-6 are
some of the pro-inﬂammatory cytokines that seem to play
ar o l ei ni m m u n ea c t i v a t i o ni nP E[ 8]. C-reactive protein
(CRP) and alpha-1-antitrypsin increase rapidly in response
to an inﬂammatory stimulus [9]. An increase in circulating
leukocytes is usually observed in inﬂammation, and cell
adhesion molecules (CAM) are crucial for the interaction
between leukocytes and endothelial cells. L-Selectin is a
glycoprotein expressed by almost all leukocytes, which is
responsible for leukocyte adhesion to the endothelium and2 Journal of Pregnancy
rolling along blood vessels [10]. With leukocyte activation,
sL-selectinisreleasedfromthesurfaceofthesecells,duepro-
teolytic cleavage. Vascular cell adhesion molecule 1 (VCAM-
1), a member of the Ig family, induces a ﬁrm leukocyte adhe-
sion to the endothelial cells, and is also released by prote-
olytic cleavage (sVCAM-1). Platelet endothelial cell adhesion
molecule 1 (PECAM-1) plays an important role in transmi-
gration of leukocytes across the endothelial layer [10].
The activation of neutrophils may occur in the presence
of some cytokines (i.e., TNF-α) and of some chemoat-
tractants released during an inﬂammatory process. During
neutrophil activation, there is a metabolic activation and
release of their granules in blood and in tissues, contributing
toincreasetheinﬂammatoryresponseand/oroxidativestress
[11]. Elastase and lactoferrin are two compounds frequently
measured in plasma to access neutrophil activation in
vivo [12]. Elastase, stored in the azurophilic granules of
neutrophils, has diﬀerent biological eﬀects, such as prote-
olytic activity and bactericidal properties; it is also involved
in cytokine induction, platelet and lymphocyte activation
[13]. Lactoferrin is a glycoprotein stored in the speciﬁc or
secondary granules of the neutrophils [12]; it is involved in
the regulation of the immune response and is associated to
an antimicrobial activity and to an anti-inﬂammatory eﬀect.
The protective action of lactoferrin is due to the reduction in
the synthesis of pro-inﬂammatory cytokines, namely, TNF-α
and IL-6 [14].
PE often associated with premature delivery and in-
creased risk for delivering newborns small for their gesta-
tional age (SGA). Few studies focused their attention on fetal
circulation, in the presence of this syndrome. In a previous
study, we showed that PE pregnancy is associated with
changes in endothelial function in fetal circulation [15].
In the present study, we searched for a possible relation
between maternal and fetal inﬂammatory modiﬁcations, in
both normal and PE pregnancies.
The aim of this study was to evaluate and compare
oxidative stress and inﬂammatory markers in maternal and
umbilical cord blood (UCB) in normal and PE pregnancies.
We measured some inﬂammatory markers, namely, acute
phase proteins (CRP and α1-antitrypsin), pro-inﬂammatory
cytokines (IL-6 and TNF-α) and leukocyte activation mark-
ers (elastase, lactoferrin, sL-selectin, sVCAM, sPECAM). To
evaluate oxidative stress, we measured total antioxidant sta-
tus (TAS), thiobarbituric acid reactive substances (TBARS)
a n du r i ca c i dl e v e l s .
2. Methods
2.1. Subjects. This study was performed under approval of
theEthicsCommitteeoftheHospitalS.Jo˜ ao,Porto,Portugal,
and every enrolled pregnant woman gave their informed
consent to participate in the study; 42 healthy pregnant
women, 46 PE pregnant women, and their neonates were
included in the study. Clinical and ultrasound evaluations
were used in the diagnoses of normal pregnant women,
and all of them presented a normal course and outcome of
pregnancy. All patients with any history of pregestational
diabetes,gestationaldiabetesmellitus,cardiovasculardisease,
renal and liver diseases, as well as in the case of fetal anoma-
lies and maternal or fetal infection, were excluded from the
study.
PE was deﬁned according to the International Society for
the Study of Hypertension in Pregnancy classiﬁcation (dias-
tolicbloodpressurehigherthan110mmHgononeoccasion,
or exceeding 90mmHg on repeated measures; proteinuria
of ≥0.3g/24h, or ≥1+ proteinuria on dipstick testing
on repeated measures, after the 20th week of gestation)
[16].
According to Portuguese guidelines [17], newborns were
deﬁned as small for gestational age (SGA) when presenting
a birth weight below the 10th percentile for gestational age,
as adequate for gestational age (AGA) when presenting a
birth weight above the 10th percentile and below the 90th
percentile for gestational age, and as large for gestational
age (LGA) when presenting a birth weight above the 90th
percentileforgestationalage.Apgarscoresat1and5minutes
were evaluated by the health caregivers responsible for im-
mediate neonatal support.
It was very diﬃcult to match normal and PE women for
gestational age, as a normal pregnancy does not associate a
premature delivery, as often occur in PE pregnancies. Con-
sidering the diﬀerences in gestational age presented by nor-
mal and PE cases, an adjustment for gestational age was per-
formed for all sets of data.
2.2. Collection and Handling of Blood Samples. Maternal
blood was collected from an antecubital vein before delivery.
UCBwascollectedimmediatelyafterdeliveryoftheplacenta.
Bloodsampleswereprocessedwithin2hoursaftercollection.
Whole blood (EDTA as anticoagulant) was used to perform
hematologicstudies.Bloodserumandplasmawereseparated
from blood cells and aliquots were stored at −70◦C until
assayed.
2.3. Biochemical Analysis. Commercially available speciﬁc
sandwich enzyme-linked immunosorbent assay (ELISA) kits
were used to evaluate plasma levels of IL-6, TNF-α,s L -
selectin (R&D Systems, Minneapolis, MN, USA), sICAM,
sPECAM (IBL Immuno-Biological Laboratories, Hamburg),
lactoferrin (Bioxytech Lactof EIA, Oxis Research, Foster City,
CA, USA), and elastase (Human PMN elastase ELISA, Ben-
der MedSystems, Vienna, Austria). CRP was determined in
serum samples by using a high-sensitivity ELISA technique,
as described elsewhere [18]. α1-antitrypsin, uric acid, and
TAS concentrations were measured by routine procedures,
using commercially available kits (α1-antitrypsin, Roche,
Basel, Switzerland; uric acid and Total Antioxidant Status,
Randox Laboratories, UK).
Leukocyte count was performed by using an auto-
matic blood cell counter (ABX Micros 60-OT, Horiva-ABX,
France). Leukocyte diﬀerential count was evaluated in
Wright stained blood ﬁlms.
TBARS was evaluated according to the method of Nie-
haus and Samuelsson described elsewhere [19].Journal of Pregnancy 3
Table 1: Clinical data of normal and PE cases at delivery.
Control pregnancies
(n = 42) PE pregnancies (n = 46) P value
Age (years) 30.4 ±5.72 9 .7 ±5.30 . 5 2
Blood Pressure (mm Hg):
Systolic 119.9 ±11.5 155.1 ±14.6 <0.001
Diastolic 69.0 ±7.29 7 .1 ±6.3 <0.001
Cases presenting proteinuria [n (%)]
Cases with 1+ — 16 (34.8%)
Cases with 2+ — 7 (15.2%)
Cases with 3+ — 13 (28.7%)
Cases with 4+ — 10 (21.7%)
Gestational age (weeks) 38.5 (38.0; 39.3) 37.0 (34.0; 38.0) <0.001
Body Mass Index (kg/m2) 29.2 (27.2; 30.8) 29.8 (26.8; 32.8) 0.16
Placental weight (g) 626.0 (542.5; 779.8) 510.0 (392.5; 560.0) <0.001
Birth weight (kg) 3.4 (3.0; 3.7) 2.6 (1.8; 3.0) <0.001
Apgar Score ≤ 7[ n (%)]:
1min 1 (2.4%) 7 (15.2%) 0.04
5min 0 (0%) 0 (0%) 1.0
SGA/AGA/LGA (n) 0/42/0 7/39/0 0.008
Cesarean section [n (%)] 31 (73.8%) 36 (78.3%) 0.63
n, number of cases; PE, preeclampsia; SGA, small for gestational age; AGA, adequate for gestational age; LGA, large for gestational age.
2.4. Statistical Analysis. Measurements are presented as
mean ± standard deviation or as median (interquartile
range). For statistical analysis, we used the Statistical Package
for Social Sciences (SPSS, version 17.0, SPSS Inc, Chicago)
for Windows. To compare the studied groups, we used the
Student’s unpaired t-test, whenever parameters presented
a Gaussian distribution, and the Mann-Whitney U-test in
the case of a non-Gaussian distribution. The number of
SGA, AGA, and LGA cases and Apgar score lower than 7
werecomparedbetweennormalandpreeclampticpregnancy
by Chi-square test. Adjustment of statistical diﬀerences for
gestational age was performed by analysis of covariance
(ANCOVA). Spearman’s rank correlation coeﬃcient was
used to evaluate relationships between sets of data. A
P value lower than 0.05 was considered as statistically
signiﬁcant.
3. Results
3.1. Patient’s Clinical Data. Clinical data from normal and
PE pregnant women, and from their neonates, are docu-
mented in Table 1. Proteinuria and high blood pressure were
characteristic of PE patients. Fetal weight, placental weight,
and gestational age were signiﬁcantly lower in PE cases,
and the number of cases with Apgar ≤7a t1m i n u t ew a s
signiﬁcantlyhigherinPEcases,ascomparedtonormalcases;
SGA newborns were observed only in the PE group. The two
groups presented similar values for maternal age and body
mass index (BMI). Considering the observed diﬀerences in
gestational age, we further adjusted our maternal and fetal
data for gestational age. First, we present the results observed
for the total sets of data and, afterwards, the results obtained
after adjustment for gestational age.
3.2. Maternal Blood. In Table 2, cytokines, acute-phase pro-
teins, and oxidative stress markers are presented for the stud-
ied groups, in normal and PE cases. We found signiﬁcantly
higher values for uric acid and TBARS in PE group and
similar values for TAS. IL-6, TNF-α, α1-antitrypsin, and
CRP concentrations were signiﬁcantly higher in PE preg-
nant women when compared with normotensive pregnant
women.
We also found signiﬁcantly higher values for basophil
count and sVCAM levels, and a trend to higher leukocyte
count in PE (Table 3). Soluble L-selectinconcentrations were
signiﬁcantly lower in PE pregnant women. No statistical
diﬀerences were observed in total leukocyte, neutrophil,
eosinophil, lymphocyte and monocyte counts, sPECAM,
elastase, and lactoferrin levels between the groups.
3.3. Umbilical Cord Blood. When comparing UCB data from
normal and preeclamptic pregnancies (Table 2), we found
similar values for IL-6, TNF-α, TAS, and TBARS; however,
signiﬁcantly higher uric acid, α1-antitrypsin and CRP values
were observed in PE.
Similar values were found for basophil count, sPECAM,
and the ratios of elastase/neutrophil, lactoferrin/neutrophil
in UCB from neonates of PE mothers. However, the new-
borns from the PE group presented signiﬁcantly lower values
for total leukocyte, neutrophil, eosinophil, lymphocyte and
monocyte counts, sL-selectin, lactoferrin, and the ratio of
elastase/α1-antitrypsin (Table 3).4 Journal of Pregnancy
Table 2: Oxidative stress parameters, cytokines, and acute-phase proteins in maternal and cord blood, in normal and PE cases.
Maternal UCB
Normal (n = 42) PE (n = 46) P Value Normal (n = 40) PE (n = 42) P Value
Uric acid (mg/dL) 4.2 ±1.35 .5 ±1.6 <0.001 4.5 ±1.1( n = 39) 5.7 ±1.6( n = 40) <0.001
TAS (mmol/L) 1.10 ±0.22 1.07 ± 0.30 . 5 5 1.23 ±0.27
(n = 39)
1.17 ±0.26
(n = 41) 0.143
TBARS (μmol/L) 1.50 (1.29; 1.81)
(n = 40)
1.87 (1.49; 2.38)
(n = 43) 0.013 1.08 (0.95; 1.26)
(n = 35)
1.10 (0.85; 1.36)
(n = 35) 0.99
TBARS/TAS 1.48 (1.19; 1.66)
(n = 40)
1.76 (1.46; 2.13)
(n = 43) 0.003 0.93 (0.76; 1.31)
(n = 35)
0.93 (0.71; 1.25)
(n = 35) 0.84
IL-6 (pg/mL) 1.9 (1.2; 6.4) 4.0 (2.3; 10.1)
(n = 42) 0.013 1.8 (1.2; 2.8) 2.2 (1.5; 5.6) 0.066
TNF-α (pg/mL) 1.2 (1.0; 1.6) 1.9 (1.3; 2.4)
(n = 43) 0.001 1.9 (1.4; 2.4) 1.8 (1.5; 2.1) 0.34
α1-Antitrypsin
(mg/dL) 191.6 ±57.0 250.5 ± 74.9 <0.001 120.2 ±30.1
(n = 39)
134.1 ±23.5
(n = 40) 0.025
CRP (mg/L) 3.1 (1.4; 5.8) 4.1 (2.5; 7.9) 0.033 0.03 (0.02; 0.04)
(n = 39) 0.04 (0.02; 0.08) 0.011
n, number of cases; PE, Preeclampsia; UCB, umbilical cord blood.
Table 3: Leukocyte activation parameters in maternal and umbilical cord blood, in normal and PE cases.
Maternal UCB
Normal (n = 42) PE (n = 46) P Value Normal (n = 39) PE (n = 42) P Value
Leukocytes (×109/L) 10.8 ±3.91 1 .90 ±3.74 0.19 12.2 ±3.5( n = 41) 9.6 ±4.8( n = 46) 0.006
Neutrophils (×109/L) 8.4 ±3.79 .17 ±3.74 0.32 5.7 ±2.1( n = 40) 4.04 ±2.8( n = 46) 0.002
Eosinophils (× 109/L) 0.07 ±0.09 0.056 ±0.093 0.38 0.5 ±0.41 (n = 40) 0.32 ± 0.35
(n = 46) 0.033
Basophils (×109/L) 0.007 ±0.026 0.025 ±0.039 0.01 0.06 ±0.077 0.035 ± 0.064 0.073
Lymphocytes (×109/L) 1.9 ±0.62 .22 ±1.06 0.10 5.19 ±1.37 4.46 ± 1.82 0.044
Monocytes (×109/L) 0.4 ±0.30 .39 ±0.21 0.89 0.86 ±0.51 0.65 ± 0.44 0.039
Metamyelocytes (n) 10 6 0.27 19 17 0.38
Myelocytes (n) 3 1 0.34 10 5 0.15
sVCAM (ng/mL) 816.1 ±200.9
(n = 38)
948.6 ±360.4
(n = 45) 0.04 2581.6 ±1081.6
(n = 34)
3101.4 ± 1090.8
(n = 39) 0.045
sPECAM (ng/mL) 146.9 ±25.5
(n = 39)
142.8 ±28.3
(n = 45) 0.49 114.0 ±17.3
(n = 35)
108.7 ±18.7
(n = 37) 0.22
sL-selectin (ng/mL) 640.6 ±119.6
(n = 38)
564.2 ±119.1
(n = 42) 0.005 697.8 ±127.5
(n = 38)
587.0 ± 148.3
(n = 42) 0.001
Elastase (ng/mL) 52.0 (39.9; 64.8)
(n = 38)
60.8 (47.6; 75.9)
(n = 41) 0.16 41.3 (27.8; 54.7)
(n = 37)
28.4 (20.7; 41.4)
(n = 41) 0.013
Elastase/Neutrophil (pg) 6.7 (5.5; 8.3)
(n = 38)
7.2 (4.7; 9.4)
(n = 41) 0.9 6.2 (5.1; 9.9)
(n = 37)
8.5 (5.3; 12.3)
(n = 41) 0.09
Elastase/α1-Antitrypsin
(×10−4)
0.27 (0.20; 0.43)
(n = 38)
0.25 (0.18; 0.32)
(n = 41) 0.22 0.33 (0.23; 0.46)
(n = 35)
0.22 (0.15; 0.34)
(n = 37) 0.007
Lactoferrin (ng/mL) 307.0 (254.5;
537.5)
331.0 (240.0;
659.0) (n = 43) 0.81 337.5 (256.3;
494.0) (n = 40)
234.0 (180.0;
376.0) (n = 43) 0.017
Lactoferrin/Neutrophil
(pg)
43.7 (30.6; 68.7)
(n = 42)
35.4 (24.2; 78.7)
(n = 40) 0.40 70.9 (42.3; 106.2)
(n = 39)
66.2 (47.5; 111.3)
(n = 41) 0.39
n, number of cases; PE, Preeclampsia; UCB, umbilical cord blood.Journal of Pregnancy 5
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Figure 1: Correlation between maternal and UCB levels of uric acid (a), TAS (b), IL-6 (c), and CRP (d), in normal and PE pregnancies.
We adjusted both maternal and UCB data for gestational
ageand afterthat, westill observed the samediﬀerences, sug-
gesting that the diﬀerences observed were not signiﬁcantly
aﬀected by gestational age.
As both normal and preeclamptic groups included about
25% of labouring cases (as referred in Table 1), we compared
eutocic versus dystocic deliveries and no diﬀerences were
found between groups.
3.4. Correlations. We found signiﬁcant positive correlations
between maternal and UCB uric acid (Figure 1(a)), in
normal pregnancy (Pearson correlation coeﬃcient, 0.70; P<
0.001) and PE pregnancy (Pearson correlation coeﬃcient,
0.68; P<0.001); a signiﬁcant positive correlation between
maternal and UCB TAS (Figure 1(b)), in normal pregnancy
(Pearson correlation coeﬃcient, 0.79; P<0.001) and PE
pregnancy (Pearson correlation coeﬃcient, 0.58; P<0.001);
a signiﬁcant positive correlation between UCB and maternal
IL-6 (Figure 1(c)) in normal pregnancy (Spearman’s cor-
relation coeﬃcient, 0.55; P<0.001) and PE pregnancy
(Spearman’s correlation coeﬃcient, 0.44; P = 0.004),
and a signiﬁcant positive correlation between maternal
CRP and UCB CRP (Figure 1(d)), in normal pregnancy
(Spearman’s correlation coeﬃcient, 0.43; P = 0.007) and
PE pregnancy (Spearman’s correlation coeﬃcient, 0.61;
P<0.001).6 Journal of Pregnancy
Maternal concentrations of sVCAM and proteinuria
were positively correlated in PE (Spearman’s correlation
coeﬃcient, 0.33; P = 0.027) (Figure 2); UCB sL-selectin
levels correlated negatively with maternal proteinuria, in
PE (Spearman’s correlation coeﬃcient, −0.45; P = 0.003)
(Figure 3).
4. Discussion and Conclusions
In this study, we conﬁrmed an enhanced inﬂammatory
process in maternal circulation, in PE. We observed in PE
women, when compared with normal pregnant women, sig-
niﬁcantlyhigherlevelsforacute-phaseproteins,namely,CRP
and α1-antitrypsin, and for the proinﬂammatory cytokines,
IL-6 and TNF-α (Table 2). The higher CRP concentrations
observedinthePEgroupareconsistentwithpreviousreports
[20–23]. Moreover, Thilaganathan et al. [22] reported that
women, who subsequently developed PE, presented signif-
icantly higher levels for CRP at a lower gestational age (16
weeks). To our knowledge, this is the ﬁrst study evaluating
α1-antitrypsin in PE. We found signiﬁcantly higher values
in PE women, which are in accordance with the enhanced
acute-phase response observed in PE, as suggested by
CRP.
The increase in the CRP levels is accompanied by an
increase in pro-inﬂammatory cytokines, in PE maternal cir-
culation. The increase in IL-6 and TNF-α levels in PE women
is in accordance with some previous studies [4, 24]; however,
other authors reported no diﬀerences between normal and
PE pregnancy for IL-6 [25, 26]a n df o rT N F - α [27]. Con-
ﬂicting results also exist concerning cytokine placental pro-
duction [28–30]. Most of these placental studies suggest that
placenta becomes a considerable source of cytokines along
pregnancy that is disturbed in PE and may contribute to the
higher levels of those cytokines, in maternal circulation.
Thereisnodoubtabouttheinvolvementofaninﬂamma-
tory process in the PE physiopathology; nevertheless, there is
no agreement about the role of leukocyte activation in PE
[2, 31]. Several studies reported that PE women present an
increasednumber oftotal leukocytes and a higher neutrophil
count [32]. Matsuo et al. [33] showed that total leukocyte
count and neutrophil number were higher in PE patients,
as compared with normotensive women, before the symp-
tomatic phase of PE. In our study, no signiﬁcant diﬀerences
were found in leukocyte and neutrophil counts; nevertheless,
we observed a trend towards higher values in the PE group
(Table 3). Basophil count was signiﬁcantly higher in PE but
this is not a consistent ﬁnding in the literature [34–36].
Contradictory ﬁndings have been reported for cellular
adhesion molecules, in placenta and in maternal circulation,
in PE. Tziotis et al. [37] reported similar values for placental
expression for PECAM-1, ICAM-1, VCAM-1, in normal and
PE pregnancies. In the present study, we found in maternal
blood, in PE, signiﬁcantly higher sVCAM concentrations,
signiﬁcantly lower sL-selectin concentrations and similar
values for sPECAM. These results are in agreement with
Chaiworapongsa et al. [38]; however, controversial results
have been published [27, 39–41].
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Figure 2: Correlation between maternal proteinuria and sVCAM,
in PE (Spearman’s correlation coeﬃcient, 0.33; P = 0.027).
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Figure 3: Correlation between maternal proteinuria and UCB sL-
selectin, in PE (Spearman’s correlation coeﬃcient, −0.45; P =
0.003).
TheincreaseinsVCAMmayreﬂectleukocyteadhesionto
the endothelium or an endothelial dysfunction. The results
concerning sL-selectin in PE are still controversial [2, 42].
Some authors proposed that under an acute inﬂammatory
condition, sL-selectin rises [43], while under a chronic
inﬂammatory condition, a decrease in circulating sL-selectin
levels occurs [44]. The decrease in sL-selectin may be aJournal of Pregnancy 7
result of downregulation of leukocyte L-selectin expression
[44], which might reﬂect a mechanism to counteract the
enhanced inﬂammatory process observed in PE. Another
possible explanation is that leukocyte L-selectin expression
is accompanied by an opposite change in the soluble form
[45, 46], thus, our results (sL-selectin decreased levels)
may indeed reﬂect an upregulation of leukocyte L-selectin
expression, improving leukocyte-endothelial interaction.
The increase in sVCAM and the decrease in sL-selectin,
in PE, suggest leukocyte adhesion to endothelial cells, even
though the similar sPECAM levels suggest that leukocyte
tissue transmigration is unlikely to occur.
In a previous study [15], we described that PE women
presented signiﬁcantly higher tPA and PAI-1 values, when
compared with normal pregnant women. Both tPA and PAI-
1, as well as sVCAM, are produced by endothelial cells. In the
same study we also described that D-dimer did not change,
though it was expected to be higher, in accordance with
the increase in tPA, which is an activator of the ﬁbrinolytic
system. All data suggest an endothelial dysfunction that
might also explain the rise observed in sVCAM, in PE
women.Moreover,theseverityofthediseasemightberelated
with endothelial dysfunction. Indeed, we found a signiﬁcant
positive correlation between sVCAM and proteinuria (an
accepted marker of severity of PE) (Figure 2), and we also
found the same type of correlation between tPA and PAI-1,
with proteinuria, in PE women [15].
Concerning markers of neutrophil degranulation, we
studied elastase and lactoferrin, but no diﬀerences were
found between normal and PE pregnant women (Table 3).
Fewstudiesmeasuredelastaseandlactoferrinlevelsinmater-
nal circulation in PE and data are not consistent [47, 48].
At ﬁrst view, we may think that elevated α1-antitrypsin
levels could mask the unchanged elastase levels, since α1-
antitrypsin is involved in elastase inhibition, but similar
values were found between the studied groups after the
calculation of elastase/α1-antitrypsin ratio. Similar results,
between normal and PE pregnant women, for elastase and
lactoferrin levels and in the ratios of elastase/neutrophil,
lactoferrin/neutrophil, and elastase/α1-antitrypsin, seem to
be indicative that PE is not associated with neutrophil
degranulation. Our results contradict previous studies,
which showed an association between PE and neutrophil
degranulation; Mellembakken et al. [49] showed an increase
in myeloperoxidase; Belo et al. [20], Gupta et al. [47], and
Lok et al. [2] observed higher elastase levels in PE; neverthe-
less, no diﬀerences were found for lactoferrin concentration
[20, 49].
The contribution of oxidative stress to PE has been
accepted, although the exact changes in antioxidants/oxi-
dants are still controversial [4, 6, 50, 51]. In our study, we
found signiﬁcantly higher levels for TBARS in PE pregnant
women, when compared with normal pregnancy, but no
diﬀerences were detected in TAS (Table 2). TBARS are a
biomarker of lipid peroxidation, and the increased levels in
maternal circulation are in accordance with the contribution
of oxidative stress to PE. TAS is used as an indicator of
the whole antioxidant capacity, thus, diﬀerent molecules
with antioxidant properties may contribute to TAS, such
as albumin, uric acid, bilirubin, vitamin C, vitamin E, and
bioﬂavonoids [52].
Higher levels of uric acid are a common characteristic
of PE patients and may contribute to the pathogenesis of
the disorder [53]. Antioxidant properties have been also
attributedtouric acid[54].Inour study, uric acidlevelswere
signiﬁcantly higher in PE and are likely to contribute to TAS
levels. Furthermore, the TBARS/TAS ratio is signiﬁcantly
elevated in PE women, and it is quite possible that this
imbalance could be caused by an enhanced oxidative stress
or a decrease in speciﬁc antioxidant compounds, or even a
contribution of both.
Few data exist concerning inﬂammation in UCB in the
presence of PE; the present study was performed in order to
analyze if the modiﬁcations observed in maternal circulation
in PE were also observed in UCB. We found evidence of
increasedinﬂammationinfetalcirculation,inthepresenceof
PE. We observed, in cord blood from PE pregnant women, a
signiﬁcant increase in CRP and α1-antitrypsin levels, a trend
towards higher values of IL-6 and no diﬀerences in TNF-
α. Contrary to our results, Braekke et al. [55]r e p o r t e dn o
diﬀerences, between newborns from PE and normotensive
pregnancies, regarding calprotectin and CRP levels.
This inﬂammatory proﬁle in UCB from PE cases was
also associated, as occurred in the mothers, with a signiﬁcant
reduction in sL-selectin and a signiﬁcant rise in sVCAM,
suggesting that a similar mechanism might underlie those
changes.
Total leukocyte number was signiﬁcantly lower in cord
blood from PE pregnancy, as well as neutrophil count. This
ﬁnding seems to be a contrasense, as usually inﬂammation
is characterized by leukocytosis and neutrophilia. Tsao et
al. [56] demonstrated that pregnancy-induced hypertension
is associated with low neutrophil count and granulocytes
colony stimulating factor (G-CSF) levels in preterm new-
borns. We did not measure G-CSF in our samples, but,
in fact, the decrease in the G-CSF may contribute to this
leucopenia, as G-CSF is an important hematopoietic growth
factor for granulocyte diﬀerentiation and proliferation [57].
Strengthening this hypothesis, a lower number of cases
presenting neutrophilic myelocytes and metamyelocytes
were identiﬁed in PE. We may also hypothesize that these
leukocyte changes might include the physiologic response to
counteract the enhanced inﬂammation observed.
Diﬀerent expressions of adhesion molecules on neu-
trophils, namely, integrins, selectins, and Ig superfamily,
wereshowntobeupregulatedininfantsfromPEpregnancies
[46, 58] suggesting an interaction between neutrophils and
endothelial cells. Nevertheless, Mellembakken et al. [46] also
reported, in the same samples, that plasma levels of soluble
L-selectin were signiﬁcantly decreased in PE infants.
No published data were found concerning plasma levels
of products released from neutrophil granules in fetal circu-
lation.Inthepresentstudy,PEinfantspresentedsigniﬁcantly
lower values for elastase and lactoferrin; after calculation
of elastase/neutrophil and lactoferrin/neutrophil, statistical
signiﬁcance was lost. These ﬁndings suggest that, as in the
mother, neutrophil degranulation does not seem to occur in
fetal circulation.8 Journal of Pregnancy
Conﬂicting results on oxidative stress in PE fetal circu-
lation are published [59–61]. In the present study, similar
values for TAS and TBARS were found between newborns
from normal and PE pregnancies. Nevertheless, infants born
from PE pregnancy presented signiﬁcantly higher uric acid
concentration, which may contribute to TAS levels in PE, as
we observed in maternal blood.
Considering the changes observed in normal and PE
c a s e s( i nm a t e r n a la n dc o r db l o o d ) ,w es t u d i e ds o m e
correlationsbetweenmaternalandUCB values,toestablisha
possible relationship between them. Increased maternal con-
centration of CRP and IL-6, in PE condition, was reﬂected
in the fetal circulation, since positive correlations were found
between maternal and UCB for both CRP and IL-6.
In summary, our data suggest that PE pregnancy is asso-
ciated with an enhanced maternal inﬂammatory condition,
also reﬂected in fetal circulation. This enhanced inﬂamma-
tory state seems to be related to endothelial dysfunction
and increased cytokine synthesis rather than with neutrophil
activation.
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